Literature DB >> 11473561

Management and outcome of patients undergoing thoracic surgery in a regional chest medical centre.

M Licker1, A Spiliopoulos, J G Frey, M De Perrot, C Chevalley, J M Tschopp.   

Abstract

BACKGROUND AND
OBJECTIVE: The main objective of this study was to assess mortality and morbidity after thoracic surgery in a medical centre, without resident chest surgeons and anaesthesiologists, and to determine specific risk factors.
METHODS: A prospective cohort study using a local database which includes patients' clinical characteristics, results of preoperative investigations, surgical and anaesthesia data and all postoperative complications was undertaken. Two hundred and seventy-three consecutive patients undergoing thoracic surgery from 1992 to 1999 were studied. The referral chest medical centre was without resident thoracic surgeons or anaesthesiologists; postoperative care was led by local chest physicians according to standardized protocols and in close collaboration with university-based surgeons and anaesthesiologists.
RESULTS: The majority of patients had lung cancer (71%) and underwent resection of at least one lobe (62%). Thirty-day mortality rate was 2.2% and one or more complications occurred in 74 patients (27%). Three patients had to be transferred to a university hospital for further treatment. Univariate predictors of complications included age (> 70 years), history of smoking, body mass index, as well as the extent and duration of surgery. After multiple logistic regression analysis, smoking (current or past), prolonged surgery (>120 min) and major lung resection (pneumonectomy or bilobectomy) remained the only independent risk factors.
CONCLUSIONS: Overall perioperative mortality and morbidity rates did not exceed those reported from large teaching hospitals. In selected patients, thoracic surgery can be safely performed in a specialized chest medical centre without on-site surgeons and anaesthesiologists.

Entities:  

Mesh:

Year:  2001        PMID: 11473561     DOI: 10.1046/j.1365-2346.2001.00890.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  7 in total

Review 1.  Lung cancer . 3: Fluorescence bronchoscopy: clinical dilemmas and research opportunities.

Authors:  A K Banerjee; P H Rabbitts; J George
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

Review 2.  Lung cancer 7: management of lung cancer in elderly patients.

Authors:  R Booton; M Jones; N Thatcher
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

3.  Risk factors for postoperative complications after lung resection for non-small cell lung cancer in elderly patients at a single institution in China.

Authors:  Guotian Pei; Shijie Zhou; Yi Han; Zhidong Liu; Shaofa Xu
Journal:  J Thorac Dis       Date:  2014-09       Impact factor: 2.895

4.  Color fluorescence ratio for detection of bronchial dysplasia and carcinoma in situ.

Authors:  Pyng Lee; Remco M van den Berg; Stephen Lam; Adi F Gazdar; Katrien Grunberg; Annette McWilliams; Jean Leriche; Pieter E Postmus; Tom G Sutedja
Journal:  Clin Cancer Res       Date:  2009-07-07       Impact factor: 12.531

5.  A risk score for predicting postoperative complications in non-intubated thoracic surgery.

Authors:  Lan Lan; Long Jiang; Chongyang Duan; Weixiang Lu; Canzhou Zhang; Yanyi Cen; Jianxing He
Journal:  J Thorac Dis       Date:  2021-07       Impact factor: 2.895

Review 6.  Perioperative medical management of patients with COPD.

Authors:  Marc Licker; Alexandre Schweizer; Christoph Ellenberger; Jean-Marie Tschopp; John Diaper; François Clergue
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

7.  Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD.

Authors:  Eun Sun Kim; Young Tae Kim; Chang Hyun Kang; In Kyu Park; Won Bae; Sun Mi Choi; Jinwoo Lee; Young Sik Park; Chang-Hoon Lee; Sang-Min Lee; Jae-Joon Yim; Young Whan Kim; Sung Koo Han; Chul-Gyu Yoo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.